Clinical trial
A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
NCT00109083 · SK Life Science, Inc., Industry · Completed
Key facts
| NCT number | NCT00109083 |
|---|---|
| Title | A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging, Multicenter Study of the Efficacy of RWJ-333369 in the Prophylaxis of Migraine |
| Lead sponsor | SK Life Science, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Migraine Headaches |
| Intervention type | Drug |
| Interventions | RWJ-333369 |
| Enrollment | 300 |
| Start date | Mar 1, 2002 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Apr 25, 2005 |
| Last update posted | Aug 2, 2012 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: